A5061818786- Veterinary medicine and infectious diseases
- Helicobacter pylori-related gastroenterology studies
- Clostridium difficile and Clostridium perfringens research
- Gastrointestinal motility and disorders
- Toxin Mechanisms and Immunotoxins
- Diverticular Disease and Complications
- COVID-19 Clinical Research Studies
- Colorectal Cancer Screening and Detection
- Congenital gastrointestinal and neural anomalies
- Long-Term Effects of COVID-19
- Asthma and respiratory diseases
- IL-33, ST2, and ILC Pathways
- Salivary Gland Tumors Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Eosinophilic Esophagitis
- Inflammatory Bowel Disease
- Concrete and Cement Materials Research
- Occupational and environmental lung diseases
- Liver Disease Diagnosis and Treatment
- Liver Diseases and Immunity
- Microscopic Colitis
- Digestive system and related health
- Inflammasome and immune disorders
- Oral Health Pathology and Treatment
- Humic Substances and Bio-Organic Studies
National Health and Medical Research Council
2022-2023
Hunter Medical Research Institute
2017-2023
University of Newcastle Australia
2019-2022
Newcastle University
2022
Australasian Gastro Intestinal Research Foundation
2022
Functional dyspepsia (FD) is a highly prevalent disorder that affects more than 10% of the population. In past decade, theoretical underpinning concept FD has begun to change, in light new data on underlying pathophysiological mechanisms this disorder, with focus duodenum. The Rome IV criteria, published 2016, note gastroesophageal reflux disease and irritable bowel syndrome overlap expected by chance, suggesting they may be part same spectrum. Infection Helicobacter pylori (H. pylori)...
Liver inflammation is a common extraintestinal manifestation in inflammatory bowel disease (IBD), yet, the mechanisms driving gut-liver axis remain poorly understood. IBD leads to breakdown integrity of intestinal barrier causing an increase portal and systemic gut-derived antigens, which challenge liver. Here, we examined role platelet activating factor receptor (PAFR) colitis-associated liver damage using dextran sulfate sodium (DSS) anti-CD40-induced colitis models. Both DSS anti-CD40...
Background: Gastrointestinal (GI) manifestations of SARS-CoV-2, designated COVID-19, have been reported, including diarrhoea, nausea, vomiting and abdominal pain. The reported prevalence GI symptoms with COVID-19 infection varied widely between studies. Here we performed a systematic review meta-analysis the aim determining associated examine correlations rates patient demographics clinical data. Methods: A search six English language databases two Chinese was conducted data independently...